Suppr超能文献

在网格蛋白介导的内吞作用过程中,β-抑制蛋白与G蛋白偶联受体的结合决定了受体重敏化的模式。

Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

作者信息

Oakley R H, Laporte S A, Holt J A, Barak L S, Caron M G

机构信息

Howard Hughes Medical Institute Laboratories, Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

J Biol Chem. 1999 Nov 5;274(45):32248-57. doi: 10.1074/jbc.274.45.32248.

Abstract

Resensitization of G protein-coupled receptors (GPCRs) following agonist-mediated desensitization is a necessary step for maintaining physiological responsiveness. However, the molecular mechanisms governing the nature of GPCR resensitization are poorly understood. Here, we examine the role of beta-arrestin in the resensitization of the beta(2) adrenergic receptor (beta(2)AR), known to recycle and resensitize rapidly, and the vasopressin V2 receptor (V2R), known to recycle and resensitize slowly. Upon agonist activation, both receptors recruit beta-arrestin to the plasma membrane and internalize in a beta-arrestin- and clathrin-dependent manner. However, whereas beta-arrestin dissociates from the beta(2)AR at the plasma membrane, it internalizes with the V2R into endosomes. The differential trafficking of beta-arrestin and the ability of these two receptors to dephosphorylate, recycle, and resensitize is completely reversed when the carboxyl-terminal tails of these two receptors are switched. Moreover, the ability of beta-arrestin to remain associated with desensitized GPCRs during clathrin-mediated endocytosis is mediated by a specific cluster of phosphorylated serine residues in the receptor carboxyl-terminal tail. These results demonstrate that the interaction of beta-arrestin with a specific motif in the GPCR carboxyl-terminal tail dictates the rate of receptor dephosphorylation, recycling, and resensitization, and thus provide direct evidence for a novel mechanism by which beta-arrestins regulate the reestablishment of GPCR responsiveness.

摘要

激动剂介导脱敏后G蛋白偶联受体(GPCRs)的再敏化是维持生理反应性的必要步骤。然而,目前对GPCR再敏化本质的分子机制了解甚少。在这里,我们研究了β-抑制蛋白在β₂肾上腺素能受体(β₂AR)再敏化中的作用,已知该受体能快速循环并再敏化;以及血管加压素V2受体(V2R),已知该受体能缓慢循环并再敏化。激动剂激活后,两种受体都将β-抑制蛋白募集到质膜,并以β-抑制蛋白和网格蛋白依赖的方式内化。然而,β-抑制蛋白在质膜上与β₂AR解离,而它与V2R一起内化到内体中。当这两种受体的羧基末端尾巴互换时,β-抑制蛋白的差异转运以及这两种受体去磷酸化、循环和再敏化的能力会完全逆转。此外,β-抑制蛋白在网格蛋白介导的内吞作用期间与脱敏GPCR保持结合的能力是由受体羧基末端尾巴中特定的磷酸化丝氨酸残基簇介导的。这些结果表明,β-抑制蛋白与GPCR羧基末端尾巴中特定基序的相互作用决定了受体去磷酸化、循环和再敏化的速率,从而为β-抑制蛋白调节GPCR反应性重建的新机制提供了直接证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验